Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Matthews

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Clinical Chemistry and Laboratory Medicine|August 6, 2021
The BACH project protocol: an international multicentre total Bile Acid Comparison and Harmonisation project and sub-study of the TURRIFIC randomised trialCorey Markus, Suzette Coat, Hanns-Ulrich Marschall, et al.
The International Journal on Drug Policy|April 17, 2025
"It's not just running the test": Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in AustraliaGrace K Burton-McKeich, Lise Lafferty, Carla Treloar, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 2, 2026
Reference intervals for haptoglobin in neonates and children 30 days to 18 years oldJad El Maamari, Vasiliki Karlaftis, Chiara Braida, et al.
The Lancet. Gastroenterology & Hepatology|February 11, 2023
A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in AustraliaJason Grebely, Corey Markus, Louise M Causer, et al.
Scientific Reports|December 15, 2019
Routine free thyroxine reference intervals are suboptimal for monitoring children on thyroxine replacement therapy and target intervals need to be assay-specificElizabeth Wheeler, Kay Weng Choy, Lit Kim Chin, et al.
Journal of Medical Internet Research|September 1, 2023
Flexible and Innovative Connectivity Solution to Support National Decentralized Infectious Diseases Point-of-Care Testing Programs in Primary Health Services: Descriptive Evaluation StudyAmit Saha, Kelly Andrewartha, Steven G Badman, et al.
The Lancet. Infectious Diseases|December 28, 2020
A decentralised point-of-care testing model to address inequities in the COVID-19 responseBelinda Hengel, Louise Causer, Susan Matthews, et al.
The Medical Journal of Australia|August 28, 2022
Roadmap to incorporating group A Streptococcus molecular point-of-care testing for remote Australia: a key activity to eliminate rheumatic heart diseaseDylan D Barth, Gelsa Cinanni, Jonathan R Carapetis, et al.
The Medical Journal of Australia|January 31, 2025
Decentralised COVID-19 molecular point-of-care testing: lessons from implementing a primary care-based network in remote Australian communitiesBelinda Hengel, Rebecca J Guy, Dawn Casey, et al.
BMC Infectious Diseases|February 28, 2024
Quality control and external quality assessment for the independent clinic-based evaluation of point-of-care testing to detect Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in eight countriesMark Shephard, Susan Matthews, Kelly Andrewartha, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Clinical Chemistry and Laboratory Medicine|August 6, 2021
The BACH project protocol: an international multicentre total Bile Acid Comparison and Harmonisation project and sub-study of the TURRIFIC randomised trialCorey Markus, Suzette Coat, Hanns-Ulrich Marschall, et al.
The International Journal on Drug Policy|April 17, 2025
"It's not just running the test": Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in AustraliaGrace K Burton-McKeich, Lise Lafferty, Carla Treloar, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|June 2, 2026
Reference intervals for haptoglobin in neonates and children 30 days to 18 years oldJad El Maamari, Vasiliki Karlaftis, Chiara Braida, et al.
The Lancet. Gastroenterology & Hepatology|February 11, 2023
A national programme to scale-up decentralised hepatitis C point-of-care testing and treatment in AustraliaJason Grebely, Corey Markus, Louise M Causer, et al.
Scientific Reports|December 15, 2019
Routine free thyroxine reference intervals are suboptimal for monitoring children on thyroxine replacement therapy and target intervals need to be assay-specificElizabeth Wheeler, Kay Weng Choy, Lit Kim Chin, et al.
Journal of Medical Internet Research|September 1, 2023
Flexible and Innovative Connectivity Solution to Support National Decentralized Infectious Diseases Point-of-Care Testing Programs in Primary Health Services: Descriptive Evaluation StudyAmit Saha, Kelly Andrewartha, Steven G Badman, et al.
The Lancet. Infectious Diseases|December 28, 2020
A decentralised point-of-care testing model to address inequities in the COVID-19 responseBelinda Hengel, Louise Causer, Susan Matthews, et al.
The Medical Journal of Australia|August 28, 2022
Roadmap to incorporating group A Streptococcus molecular point-of-care testing for remote Australia: a key activity to eliminate rheumatic heart diseaseDylan D Barth, Gelsa Cinanni, Jonathan R Carapetis, et al.
The Medical Journal of Australia|January 31, 2025
Decentralised COVID-19 molecular point-of-care testing: lessons from implementing a primary care-based network in remote Australian communitiesBelinda Hengel, Rebecca J Guy, Dawn Casey, et al.
BMC Infectious Diseases|February 28, 2024
Quality control and external quality assessment for the independent clinic-based evaluation of point-of-care testing to detect Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in eight countriesMark Shephard, Susan Matthews, Kelly Andrewartha, et al.
Pageof 4